A Vail Health Learning Lab
Generously sponsored by Tony & Pat McMunn
What if an unexpected area of research could help unlock new insights into how we age? Join Dr. Louise Hecker of Baylor College of Medicine as she shares her pioneering preclinical research on psilocybin and its potential impact on the biological processes linked to aging.
Drawing on studies in cellular and animal models, Dr. Hecker will discuss her latest findings on how psilocybin may influence inflammation, organ health, protection of DNA, and other impacts associated with longevity. She will also share how this early research is helping shape the next phase of study in humans, including her collaboration with Vail Health on the LONG-LIFE clinical trial, which is investigating the effects of psilocybin on biomarkers of aging and well-being.
Whether you’re interested in healthy aging, cutting-edge medical research, or the future of psychedelic science, this free community event offers an inside look at this emerging science and a chance to learn from a leading expert.
5:30pm | Doors open
6:00pm | Program begins
After the talk, connect with our team and learn more about what the Vail Health Behavioral Health Innovation Center, Vail Healthspan, and local providers have to offer. Light refreshments will be served.
Registration is through Vail Health by clicking the button below or by contacting Events@VailHealth.org or (970) 569-7766.
